Home self-sampling for cervical cancer prevention in Ghana
Treatments studied
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study tests at-home self-sampling kits to help prevent cervical cancer in women living with HIV in Ghana. Participation is completely voluntary, involves collecting your own sample at home, and aims to make screening easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 65 years old living with HIV.
- You have never had a Pap or HPV test, or your last screening was more than 5 years ago.
- You have not had your uterus removed (hysterectomy) and you are not pregnant.
- You live in the Central Region of Ghana.
- You are willing to be part of the study and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers a take-home HPV test kit so women living with HIV can check for cervical cancer risk without a clinic visit. It aims to make screening easier and more convenient.
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
This trial tests if women can collect their own samples at home to check for HPV, a virus that can cause cervical cancer. It aims to make screening easier during the war in Ukraine.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study aims to improve how women living with HIV are screened and treated for cervical cancer in Kenya. It involves focus groups and a screening program to find better ways to prevent cancer.
Hear when a new Cervical Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.